Liberty Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8
Closed -$4K 434
2021
Q3
$4K Buy
8
+4
+100% +$1.52K ﹤0.01% 972
2021
Q2
$2K Buy
+4
New +$1.53K ﹤0.01% 914
2021
Q1
Sell
-6
Closed -$1K 961
2020
Q4
$1K Buy
6
+2
+50% +$614 ﹤0.01% 857
2020
Q3
$1K Hold
4
﹤0.01% 798
2020
Q2
$1K Buy
+4
New +$1.07K ﹤0.01% 777
2019
Q4
Sell
-110
Closed -$27K 921
2019
Q3
$27K Sell
110
-9
-8% -$2.47K 0.03% 339
2019
Q2
$34K Sell
119
-7
-6% -$1.91K 0.03% 312
2019
Q1
$36K Buy
+126
New +$36.4K 0.03% 254

Other funds holding ELV

Liberty Wealth Management's ELV Position: Q4 2021 in Review

Liberty Wealth Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 8 shares — an estimated $4K sold.

Liberty Wealth Management first reported a position in ELV in Q1 2019 and held it in 8 quarters. The position peaked at $36K in Q1 2019. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Liberty Wealth Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 8 Elevance Health shares in Q4 2021, an estimated $4K.
  • Liberty Wealth Management first reported a position in Elevance Health in Q1 2019 and held it in 8 quarters.
  • Liberty Wealth Management's Elevance Health position peaked at $36K in Q1 2019.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.